171.89

+0.7%↑

100.6

+0.78%↑

BMO

144.25

+1.09%↑

103.13

+0.6%↑

BNS

72.85

+0.97%↑

171.89

+0.7%↑

100.6

+0.78%↑

BMO

144.25

+1.09%↑

103.13

+0.6%↑

BNS

72.85

+0.97%↑

171.89

+0.7%↑

100.6

+0.78%↑

BMO

144.25

+1.09%↑

103.13

+0.6%↑

BNS

72.85

+0.97%↑

171.89

+0.7%↑

100.6

+0.78%↑

BMO

144.25

+1.09%↑

103.13

+0.6%↑

BNS

72.85

+0.97%↑

171.89

+0.7%↑

100.6

+0.78%↑

BMO

144.25

+1.09%↑

103.13

+0.6%↑

BNS

72.85

+0.97%↑

Home・Akciju saraksts・Walker & Dunlop Inc

Walker & Dunlop Inc

Slēgts

SektorsFinanšu

46.71 2.21

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

45.38

Max

46.82

Galvenie mērījumi
By Trading Economics
Ienākumi	-47M -14M
Pārdošana	2.3M 340M
P/E Sektora vidējais	27.512 37.917
Dividenžu ienesīgums	6.03
Peļņas marža	-4.087
Darbinieki	1,466
EBITDA	-46M 60M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+43.58% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	6.03% 4.79%
Nākamie ieņēmumi	2026. g. 30. apr.
Nākamais dividenžu datums	2026. g. 28. maijs
Nākamais Ex dividenžu datums	2026. g. 14. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-550M 1.5B
Iepriekšējā atvēršanas cena	44.5
Iepriekšējā slēgšanas cena	46.71

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

70.995 / 76.69 Atbalsts un pretestība

Walker & Dunlop Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. apr. 17:04 UTC

Galvenie tirgus virzītāji

FDA Rejects Replimune's Melanoma Drug for a Second Time

2026. g. 11. apr. 00:00 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

Big Yachts, Big Bucks -- Barrons.com

2026. g. 10. apr. 21:55 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

2026. g. 10. apr. 21:01 UTC

Peļņas

Cango Inc.: Files Annual Report on Form 20-F With SEC

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 10. apr. 20:31 UTC

Tirgus saruna

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

2026. g. 10. apr. 20:10 UTC

Iegādes, apvienošanās, pārņemšana

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

2026. g. 10. apr. 19:15 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2026. g. 10. apr. 19:15 UTC

Tirgus saruna

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

2026. g. 10. apr. 19:08 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 10. apr. 19:08 UTC

Tirgus saruna

U.S. Natural Gas Futures End Week Lower -- Market Talk

2026. g. 10. apr. 18:38 UTC

Tirgus saruna

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

2026. g. 10. apr. 18:25 UTC

Tirgus saruna

Galvenie ziņu notikumi

Precious Metals Finish With Weekly Gains -- Market Talk

2026. g. 10. apr. 18:05 UTC

Tirgus saruna

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

2026. g. 10. apr. 17:31 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

2026. g. 10. apr. 17:26 UTC

Peļņas

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

2026. g. 10. apr. 17:10 UTC

Tirgus saruna

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

2026. g. 10. apr. 17:00 UTC

Galvenie ziņu notikumi

Construction Business Taking a Hit From Iran Conflict -- WSJ

2026. g. 10. apr. 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 10. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 10. apr. 16:12 UTC

Peļņas

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

2026. g. 10. apr. 16:11 UTC

Peļņas

Partners Group: Traditional Programs Contributed $3.3B

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group: $5B of New Commitments Came From Bespoke Solutions

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group 1Q New Client Demand $8.3B

2026. g. 10. apr. 16:09 UTC

Peļņas

Partners Group Continued to See Positive Fundraising Momentum in 1Q

2026. g. 10. apr. 15:54 UTC

Iegādes, apvienošanās, pārņemšana

Plenitude Completes Acquisition of Acea Energia

2026. g. 10. apr. 15:38 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Walker & Dunlop Inc Prognoze

Cenas mērķis

By TipRanks

43.58% augšup

Prognoze 12 mēnešiem

Vidējais 65 USD 43.58%

Augstākais 65 USD

Zemākais 65 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Walker & Dunlop Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Walker & Dunlop Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

70.995 / 76.69Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.